RT @Fil_Bednar: OK, now we have data for adjuvant mFOLFIRINOX in pancreatic cancer. Interesting to compare with EsPAC-4. Even the gem group…
So far, Altmetric has seen 216 tweets from 188 users, with an upper bound of 809,422 followers.
RT @AESPANC: Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (…